Charles Schwab’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20
| Closed | -$29K | – | 3510 |
|
|
2022
Q2 | $29K | Sell |
20
-27
| -57% | -$39.2K | ﹤0.01% | 3476 |
|
|
2022
Q1 | $99K | Sell |
47
-7
| -13% | -$14.7K | ﹤0.01% | 3414 |
|
|
2021
Q4 | $265K | Buy |
54
+8
| +17% | +$39.3K | ﹤0.01% | 3306 |
|
|
2021
Q3 | $290K | Sell |
46
-6
| -12% | -$37.8K | ﹤0.01% | 3274 |
|
|
2021
Q2 | $494K | Buy |
52
+7
| +16% | +$66.5K | ﹤0.01% | 3170 |
|
|
2021
Q1 | $394K | Buy |
45
+6
| +15% | +$52.5K | ﹤0.01% | 3161 |
|
|
2020
Q4 | $300K | Hold |
39
| – | – | ﹤0.01% | 3160 |
|
|
2020
Q3 | $259K | Buy |
39
+16
| +70% | +$106K | ﹤0.01% | 3089 |
|
|
2020
Q2 | $176K | Buy |
23
+4
| +21% | +$30.6K | ﹤0.01% | 3189 |
|
|
2020
Q1 | $137K | Hold |
19
| – | – | ﹤0.01% | 3071 |
|
|
2019
Q4 | $297K | Buy |
19
+2
| +12% | +$31.3K | ﹤0.01% | 2975 |
|
|
2019
Q3 | $165K | Sell |
17
-1
| -6% | -$9.71K | ﹤0.01% | 3062 |
|
|
2019
Q2 | $288K | Buy |
+18
| New | +$288K | ﹤0.01% | 3026 |
|